The Washington State Liquor and Cannabis Board (Board) has issued an Interim Policy that warns firms against using claims that cannabis and cannabis infused CBD products offer curative or therapeutic effects. Washington regulations prohibit advertisements from incorporating claims regarding a product’s curative or therapeutic effects. The Board clarified that the phrase curative or therapeutic effects includes statements that the product will:
effect the body or mind;
produce a useful or favorable result or effect;
impact the consumers health; or
contains such words as “relief, remedy, healing, curative, remedial, medicinal, restorative, beneficial, corrective, wellness, well-being, salutary, salubrious, and support are prohibited. Including the phrase, “This product is not approved by the FDA to treat, cure, or prevent any disease” “
The Interim Policy is the latest guidance issued by the Board as it implements its packaging and labeling regulatory regime.